The PPSV is recommended for adults 65 years and older, individuals aged 2-64 with specific chronic conditions (such as heart disease, diabetes, or lung diseases), and those with weakened immune systems. It is also advised for residents of nursing homes and other long-term care facilities. The vaccine is not typically administered to healthy children, as the pneumococcal conjugate vaccine (PCV) is preferred for younger populations.
